-
1
-
-
0342894822
-
Interferon α-2a and interleukin-2 with or without cisplatin in metastatic melanoma: A randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
-
Keilholz, U., S. H. Goey, C. J. Punt, T. M. Proebstle, R. Salzmann, C. Scheibenbogen, D. Schadendorf, D. Liénard, A. Enk, R. Dummer, et al. 1997. Interferon α-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J. Clin. Oncol. 15: 2579-2588.
-
(1997)
J. Clin. Oncol.
, vol.15
, pp. 2579-2588
-
-
Keilholz, U.1
Goey, S.H.2
Punt, C.J.3
Proebstle, T.M.4
Salzmann, R.5
Scheibenbogen, C.6
Schadendorf, D.7
Liénard, D.8
Enk, A.9
Dummer, R.10
-
2
-
-
0032976897
-
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon α-2b
-
Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, C. A. Seipp, J. H. Einhorn, D. E. White, and S. M. Steinberg. 1999. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon α-2b. J. Clin. Oncol. 17: 968-975.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 968-975
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
Hwu, P.4
Marincola, F.M.5
Topalian, S.L.6
Seipp, C.A.7
Einhorn, J.H.8
White, D.E.9
Steinberg, S.M.10
-
3
-
-
0037089629
-
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial
-
Eton, O., S. S. Legha, A. Y. Bedikian, J. J. Lee, A. C. Buzaid, C. Hodges, S. E. Ring, N. E. Papadopoulos, C. Plager, M. J. East, et al. 2002. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J. Clin. Oncol. 20: 2045-2052.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 2045-2052
-
-
Eton, O.1
Legha, S.S.2
Bedikian, A.Y.3
Lee, J.J.4
Buzaid, A.C.5
Hodges, C.6
Ring, S.E.7
Papadopoulos, N.E.8
Plager, C.9
East, M.J.10
-
4
-
-
1642275644
-
A prospective randomized phase III trial of concurrent biochemotherapy (BCT) with cisplatin, vinblastine, dacarbazine (CVD), IL-2, and interferon α-2b (IFN) versus CVD alone in patients with metastatic melanoma (E3695): An ECOG-coordinated intergroup trial
-
Atkins, M. B., S. Lee, L. E. Flaherty, J. A. Sosman, V. K. Sondak, and J. M. Kirkwood. 2003. A prospective randomized phase III trial of concurrent biochemotherapy (BCT) with cisplatin, vinblastine, dacarbazine (CVD), IL-2, and interferon α-2b (IFN) versus CVD alone in patients with metastatic melanoma (E3695): an ECOG-coordinated intergroup trial. In: Program and abstracts of the American Society of Clinical Oncology Annual Meeting; May 31-June 3, 2003; Chicago, IL. p. 708a.
-
(2003)
Program and Abstracts of the American Society of Clinical Oncology Annual Meeting; May 31-June 3, 2003; Chicago, IL
-
-
Atkins, M.B.1
Lee, S.2
Flaherty, L.E.3
Sosman, J.A.4
Sondak, V.K.5
Kirkwood, J.M.6
-
5
-
-
27244432257
-
Dacarbazine, cisplatin, and interferon-α-2b with or without interleukin-2 in metastatic melanoma: A randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group
-
Keilholz, U., C. J. Punt, M. Gore, W. Kruit, P. Patel, D. Lienard, J. Thomas, T. M. Proebstle, A. Schmittel, D. Schadendorf, et al. 2005. Dacarbazine, cisplatin, and interferon-α-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. J. Clin. Oncol. 23: 6747-6755.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 6747-6755
-
-
Keilholz, U.1
Punt, C.J.2
Gore, M.3
Kruit, W.4
Patel, P.5
Lienard, D.6
Thomas, J.7
Proebstle, T.M.8
Schmittel, A.9
Schadendorf, D.10
-
6
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
-
Dudley, M. E., J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu, D. J. Schwartzentruber, S. L. Topalian, R. Sherry, N. P. Restifo, A. M. Hubicki, et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850-854.
-
(2002)
Science
, vol.298
, pp. 850-854
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Robbins, P.F.3
Yang, J.C.4
Hwu, P.5
Schwartzentruber, D.J.6
Topalian, S.L.7
Sherry, R.8
Restifo, N.P.9
Hubicki, A.M.10
-
7
-
-
20244366111
-
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
-
Dudley, M. E., J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula, D. E. White, S. A. Mavroukakis, et al. 2005. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23: 2346-2357.
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 2346-2357
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Yang, J.C.3
Sherry, R.M.4
Topalian, S.L.5
Restifo, N.P.6
Royal, R.E.7
Kammula, U.8
White, D.E.9
Mavroukakis, S.A.10
-
8
-
-
0038195719
-
Molecular mechanisms regulating Th1 immune responses
-
Szabo, S. J., B. M. Sullivan, S. L. Peng, and L. H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758.
-
(2003)
Annu. Rev. Immunol.
, vol.21
, pp. 713-758
-
-
Szabo, S.J.1
Sullivan, B.M.2
Peng, S.L.3
Glimcher, L.H.4
-
9
-
-
0016723594
-
An endotoxin-induced serum factor that causes necrosis of tumors
-
Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72: 3666-3670.
-
(1975)
Proc. Natl. Acad. Sci. USA
, vol.72
, pp. 3666-3670
-
-
Carswell, E.A.1
Old, L.J.2
Kassel, R.L.3
Green, S.4
Fiore, N.5
Williamson, B.6
-
10
-
-
0022369998
-
Tumor necrosis factor (TNF)
-
Old, L. J. 1985. Tumor necrosis factor (TNF). Science 230: 630-632.
-
(1985)
Science
, vol.230
, pp. 630-632
-
-
Old, L.J.1
-
11
-
-
0016590392
-
Effect of tumor necrosis factor on cultured human melanoma cells
-
Helson, L., S. Green, E. Carswell, and L. J. Old. 1975. Effect of tumor necrosis factor on cultured human melanoma cells. Nature 258: 731-732.
-
(1975)
Nature
, vol.258
, pp. 731-732
-
-
Helson, L.1
Green, S.2
Carswell, E.3
Old, L.J.4
-
12
-
-
0022382737
-
Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro
-
Sugarman, B. J., B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr., and H. M. Shepard. 1985. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945. (Pubitemid 16193990)
-
(1985)
Science
, vol.230
, Issue.4728
, pp. 943-945
-
-
Sugarman, B.J.1
Aggarwal, B.B.2
Hass, P.E.3
-
13
-
-
0023697978
-
Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis
-
Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
-
(1988)
J. Immunol.
, vol.141
, pp. 2629-2634
-
-
Laster, S.M.1
Wood, J.G.2
Gooding, L.R.3
-
14
-
-
0023691110
-
Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor
-
Rubin, B. Y., L. J. Smith, G. R. Hellermann, R. M. Lunn, N. K. Richardson, and S. L. Anderson. 1988. Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res. 48: 6006-6010. (Pubitemid 18266791)
-
(1988)
Cancer Research
, vol.48
, Issue.21
, pp. 6006-6010
-
-
Rubin, B.Y.1
Smith, L.J.2
Hellermann, G.R.3
Lunn, R.M.4
Richardson, N.K.5
Anderson, S.L.6
-
15
-
-
0029985727
-
Synergistic antitumour effect of recombinant human tumour necrosis factor α with melphalan in isolated limb perfusion in the rat
-
Manusama, E. R., P. T. Nooijen, J. Stavast, N. M. Durante, R. L. Marquet, and A. M. Eggermont. 1996. Synergistic antitumour effect of recombinant human tumour necrosis factor α with melphalan in isolated limb perfusion in the rat. Br. J. Surg. 83: 551-555.
-
(1996)
Br. J. Surg.
, vol.83
, pp. 551-555
-
-
Manusama, E.R.1
Nooijen, P.T.2
Stavast, J.3
Durante, N.M.4
Marquet, R.L.5
Eggermont, A.M.6
-
16
-
-
0023877120
-
Toxic effect of tumor necrosis factor on tumor vasculature in mice
-
Watanabe, N., Y. Niitsu, H. Umeno, H. Kuriyama, H. Neda, N. Yamauchi, M. Maeda, and I. Urushizaki. 1988. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 48: 2179-2183.
-
(1988)
Cancer Res.
, vol.48
, pp. 2179-2183
-
-
Watanabe, N.1
Niitsu, Y.2
Umeno, H.3
Kuriyama, H.4
Neda, H.5
Yamauchi, N.6
Maeda, M.7
Urushizaki, I.8
-
17
-
-
33645782015
-
TNF-α in cancer treatment: Molecular insights, antitumor effects, and clinical utility
-
van Horssen, R., T. L. Ten Hagen, and A. M. Eggermont. 2006. TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11: 397-408.
-
(2006)
Oncologist
, vol.11
, pp. 397-408
-
-
Van Horssen, R.1
Ten Hagen, T.L.2
Eggermont, A.M.3
-
18
-
-
0033922513
-
The role of p21 in interferon γ-mediated growth inhibition of human breast cancer cells
-
Gooch, J. L., R. E. Herrera, and D. Yee. 2000. The role of p21 in interferon γ-mediated growth inhibition of human breast cancer cells. Cell Growth Differ. 11: 335-342.
-
(2000)
Cell Growth Differ.
, vol.11
, pp. 335-342
-
-
Gooch, J.L.1
Herrera, R.E.2
Yee, D.3
-
19
-
-
0034913431
-
Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis
-
Detjen, K. M., K. Farwig, M. Welzel, B. Wiedenmann, and S. Rosewicz. 2001. Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49: 251-262.
-
(2001)
Gut
, vol.49
, pp. 251-262
-
-
Detjen, K.M.1
Farwig, K.2
Welzel, M.3
Wiedenmann, B.4
Rosewicz, S.5
-
20
-
-
0037790592
-
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
-
Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
-
(2003)
Apoptosis
, vol.8
, pp. 237-249
-
-
Chawla-Sarkar, M.1
Lindner, D.J.2
Liu, Y.F.3
Williams, B.R.4
Sen, G.C.5
Silverman, R.H.6
Borden, E.C.7
-
21
-
-
0034895641
-
Preferential induction of apoptosis by interferon (IFN)-β compared with IFN-α2: Correlation with TRAIL/Apo2L induction in melanoma cell lines
-
Chawla-Sarkar, M., D. W. Leaman, and E. C. Borden. 2001. Preferential induction of apoptosis by interferon (IFN)-β compared with IFN-α2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin. Cancer Res. 7: 1821-1831. (Pubitemid 32708654)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.6
, pp. 1821-1831
-
-
Chawla-Sarkar, M.1
Leaman, D.W.2
Borden, E.C.3
-
22
-
-
0032526030
-
Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons
-
Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58: 2489-2499.
-
(1998)
Cancer Res.
, vol.58
, pp. 2489-2499
-
-
Pfeffer, L.M.1
Dinarello, C.A.2
Herberman, R.B.3
Williams, B.R.4
Borden, E.C.5
Bordens, R.6
Walter, M.R.7
Nagabhushan, T.L.8
Trotta, P.P.9
Pestka, S.10
-
23
-
-
0032560475
-
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
-
Kaplan, D. H., V. Shankaran, A. S. Dighe, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95: 7556-7561.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 7556-7561
-
-
Kaplan, D.H.1
Shankaran, V.2
Dighe, A.S.3
Stockert, E.4
Aguet, M.5
Old, L.J.6
Schreiber, R.D.7
-
24
-
-
0029832323
-
Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma
-
Harvat, B. L., and A. M. Jetten. 1996. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Differ. 7: 289-300.
-
(1996)
Cell Growth Differ.
, vol.7
, pp. 289-300
-
-
Harvat, B.L.1
Jetten, A.M.2
-
25
-
-
0031066833
-
Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-γ
-
Phan-Bich, L., A. Buard, J. F. Petit, L. Zeng, J. P. Tenu, P. Chretien, I. Monnet, C. Boutin, J. Bignon, G. Lemaire, and M. C. Jaurand. 1997. Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-γ. Am. J. Respir. Cell Mol. Biol. 16: 178-186.
-
(1997)
Am. J. Respir. Cell Mol. Biol.
, vol.16
, pp. 178-186
-
-
Phan-Bich, L.1
Buard, A.2
Petit, J.F.3
Zeng, L.4
Tenu, J.P.5
Chretien, P.6
Monnet, I.7
Boutin, C.8
Bignon, J.9
Lemaire, G.10
Jaurand, M.C.11
-
26
-
-
0032987795
-
Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA
-
Burke, F., P. D. Smith, M. R. Crompton, C. Upton, and F. R. Balkwill. 1999. Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA. Br. J. Cancer 80: 1236-1244.
-
(1999)
Br. J. Cancer
, vol.80
, pp. 1236-1244
-
-
Burke, F.1
Smith, P.D.2
Crompton, M.R.3
Upton, C.4
Balkwill, F.R.5
-
27
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou, T. C., and P. Talalay. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27-55.
-
(1984)
Adv. Enzyme Regul.
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
28
-
-
0033969322
-
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
-
Jaiswal, M., N. F. LaRusso, L. J. Burgart, and G. J. Gores. 2000. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60: 184-190. (Pubitemid 30058750)
-
(2000)
Cancer Research
, vol.60
, Issue.1
, pp. 184-190
-
-
Jaiswal, M.1
Larusso, N.F.2
Burgart, L.J.3
Gores, G.J.4
-
29
-
-
57749103278
-
IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression
-
Rosati, S. F., R. F. Williams, L. C. Nunnally, M. C. McGee, T. L. Sims, L. Tracey, J. Zhou, M. Fan, C. Y. Ng, A. C. Nathwani, et al. 2008. IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression. Mol. Cancer Ther. 7: 3852-3858.
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 3852-3858
-
-
Rosati, S.F.1
Williams, R.F.2
Nunnally, L.C.3
McGee, M.C.4
Sims, T.L.5
Tracey, L.6
Zhou, J.7
Fan, M.8
Ng, C.Y.9
Nathwani, A.C.10
-
30
-
-
57749115016
-
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells
-
Zheng, M., D. Bocangel, R. Ramesh, S. Ekmekcioglu, N. Poindexter, E. A. Grimm, and S. Chada. 2008. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Mol. Cancer Ther. 7: 3842-3851.
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 3842-3851
-
-
Zheng, M.1
Bocangel, D.2
Ramesh, R.3
Ekmekcioglu, S.4
Poindexter, N.5
Grimm, E.A.6
Chada, S.7
-
31
-
-
0036789674
-
Clearance of radiationinduced apoptotic lymphocytes: Ex vivo studies and an in vitro co-culture model
-
Benderitter, M., V. Durand, C. Caux, and P. Voisin. 2002. Clearance of radiationinduced apoptotic lymphocytes: ex vivo studies and an in vitro co-culture model. Radiat. Res. 158: 464-474.
-
(2002)
Radiat. Res.
, vol.158
, pp. 464-474
-
-
Benderitter, M.1
Durand, V.2
Caux, C.3
Voisin, P.4
-
32
-
-
0033934036
-
New strategies in allogeneic stem cell transplantation: Immunotherapy using irradiated allogeneic T cells
-
Waller, E. K., and M. Boyer. 2000. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells. Bone Marrow Transplant. 25, Suppl. 2: S20-S24.
-
(2000)
Bone Marrow Transplant.
, vol.25
, Issue.SUPPL. 2
-
-
Waller, E.K.1
Boyer, M.2
-
33
-
-
4143103624
-
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
-
Wheeler, C. J., A. Das, G. Liu, J. S. Yu, and K. L. Black. 2004. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin. Cancer Res. 10: 5316-5326.
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 5316-5326
-
-
Wheeler, C.J.1
Das, A.2
Liu, G.3
Yu, J.S.4
Black, K.L.5
-
34
-
-
20444496893
-
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy
-
Gribben, J. G., D. P. Ryan, R. Boyajian, R. G. Urban, M. L. Hedley, K. Beach, P. Nealon, U. Matulonis, S. Campos, T. D. Gilligan, et al. 2005. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin. Cancer Res. 11: 4430-4436.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 4430-4436
-
-
Gribben, J.G.1
Ryan, D.P.2
Boyajian, R.3
Urban, R.G.4
Hedley, M.L.5
Beach, K.6
Nealon, P.7
Matulonis, U.8
Campos, S.9
Gilligan, T.D.10
-
35
-
-
32944468708
-
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
-
Antonia, S. J., N. Mirza, I. Fricke, A. Chiappori, P. Thompson, N. Williams, G. Bepler, G. Simon, W. Janssen, J. H. Lee, et al. 2006. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clin. Cancer Res. 12: 878-887.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 878-887
-
-
Antonia, S.J.1
Mirza, N.2
Fricke, I.3
Chiappori, A.4
Thompson, P.5
Williams, N.6
Bepler, G.7
Simon, G.8
Janssen, W.9
Lee, J.H.10
-
36
-
-
33644760431
-
A randomized Phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
-
Arlen, P. M., J. L. Gulley, C. Parker, L. Skarupa, M. Pazdur, D. Panicali, P. Beetham, K. Y. Tsang, D. W. Grosenbach, J. Feldman, et al. 2006. A randomized Phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Clin. Cancer Res. 12: 1260-1269.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1260-1269
-
-
Arlen, P.M.1
Gulley, J.L.2
Parker, C.3
Skarupa, L.4
Pazdur, M.5
Panicali, D.6
Beetham, P.7
Tsang, K.Y.8
Grosenbach, D.W.9
Feldman, J.10
-
37
-
-
34447136106
-
Cancer vaccines: Moving beyond current paradigms
-
Schlom, J., P. M. Arlen, and J. L. Gulley. 2007. Cancer vaccines: moving beyond current paradigms. Clin. Cancer Res. 13: 3776-3782.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 3776-3782
-
-
Schlom, J.1
Arlen, P.M.2
Gulley, J.L.3
|